Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stalevo in Parkinson's disease patients with early wearing-off (SENSE)
NCT00462007Phase 4Completed
- Sponsor
- Orion Corporation
- Start
- Sep 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of entacapone in Parkinson's disease (PD), sponsored by Orion Corporation. Started Sep 2006; status: completed.
02
Drugs
entacapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00462007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00462007.